Pharmaq invests in production

Pharmaq is investing in new fish vaccine production facilities close to home Photo: Pharmaq

Norwegian fish vaccine manufacturer Pharmaq has chosen to invest heavily in large-scale GMP production of viruses for fish vaccines in a new facility at Kløfta, its largest ever investment.

Continue this article…

Already subscribed? SIGN IN now


Sign up for FREE to continue this article!

Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy:

  • Weekly newsletters providing valuable news and information on the commercial fishing and aquaculture sector
  • Full access to our news archive
  • Live and archived webinars, podcasts and videos
  • Articles on innovations and current trends in the commercial fishing industry
  • Our extensive archive of data, research and intelligence

Get more free content sign up today

Ready to subscribe? Choose from one of our subscription packages for unlimited access!